[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"updates-archive-2026-08-07-27":3},{"date":4,"filings":5,"has_more":69,"limit":70,"page":71,"total_count":72},"2026-08-07",[6,14,22,29,36,43,50,57,64],{"company_name":7,"filing_date":8,"filing_source":9,"headline":10,"id":11,"stock_code":12,"summary_text":13},"NDA Securities Ltd","2026-08-07T02:13:28.201000","BSE","Independent Director Steps Down","6a74f2126da41605fd85edff","511535","• Ms. Isha Rastogi has resigned from her position as an Independent Director, effective August 6, 2026.\n• The reason cited for the resignation is \"personal and unavoidable circumstances.\"\n• The company has confirmed that there are no other material reasons for her departure.",{"company_name":15,"filing_date":16,"filing_source":17,"headline":18,"id":19,"stock_code":20,"summary_text":21},"Kokuyo Camlin Limited","2026-08-07T01:28:27.038000","NSE","[Key Takeaways from the 79th Annual General Meeting]","6a74e7a0179efb336c228353","KOKUYOCMLN","*   A dividend of \u003Cb>₹0.30 per share\u003C\u002Fb> for the financial year 2025-26 was proposed and put to a shareholder vote.\n*   Resolutions were voted on for the re-appointment of Director Mr. Masaharu Inoue and the continuation of Chairman Mr. Dilip D. Dandekar.\n*   The auditor's report included an observation regarding the \"possible effect\" of a prior year's inventory discrepancy on the current year's financial comparability.\n*   The final voting results on all resolutions will be declared within two working days of the AGM.",{"company_name":23,"filing_date":24,"filing_source":17,"headline":25,"id":26,"stock_code":27,"summary_text":28},"Lupin Limited","2026-08-07T01:18:27.035000","Stellar Q1 FY27 Performance: Lupin's Revenue Jumps 33%","6a74e54fceb4d5c3178799a5","LUPIN","*   \u003Cb>Overall Performance (Q1 FY27):\u003C\u002Fb> Net Sales grew 33.3% YoY to ₹82,172 mn. EBITDA margin stood strong at 30.0%, with Net Income at ₹14,150 mn.\n*   \u003Cb>Segment Highlights:\u003C\u002Fb> North America sales surged 43% YoY to ₹35,908 mn. Exceptional growth was also seen in LATAM (71%), ROW (69%), and EMEA (65%).\n*   \u003Cb>US Market Strength:\u003C\u002Fb> Maintained #3 position by Gx TRx volume share. Key products like Tiotropium captured ~35% market share.\n*   \u003Cb>Key Approvals:\u003C\u002Fb> Received US FDA approval for Ranibizumab (Ranluspect™) biosimilar, a significant pipeline milestone.\n*   \u003Cb>Future Outlook:\u003C\u002Fb> The company plans to launch 15+ new products in the US and 20+ in India during FY27, focusing on complex generics and biosimilars.\n*   \u003Cb>ESG Leadership:\u003C\u002Fb> Ranked #1 globally in the pharma sector by the 2025 S&P Global ESG Rating with a score of 91\u002F100.",{"company_name":30,"filing_date":31,"filing_source":17,"headline":32,"id":33,"stock_code":34,"summary_text":35},"Krsnaa Diagnostics Limited","2026-08-07T00:58:27.034000","Board Meeting on Aug 13 to Consider Q1 Results & Fundraising","6a74e07c179efb336c228334","KRSNAA","• The Board of Directors will meet on August 13, 2026.\n• The agenda includes the consideration and approval of the unaudited financial results for the quarter ending June 30, 2026.\n• The Board will also consider a proposal for fundraising through a Preferential Issue.",{"company_name":37,"filing_date":38,"filing_source":17,"headline":39,"id":40,"stock_code":41,"summary_text":42},"Parag Milk Foods Limited","2026-08-07T00:33:27.099000","Q1 FY27 Results: Revenue Up 11%, Board Approves ₹105 Cr Capex & New CFO","6a74dad1ceb4d5c317879976","PARAGMILK","*   \u003Cb>Q1 FY27 Financials:\u003C\u002Fb> Revenue grew 11% YoY to ₹945 Cr, while PAT declined 20% YoY to ₹22 Cr, impacted by higher taxes and input costs.\n*   \u003Cb>Major Capex Approved:\u003C\u002Fb> The Board sanctioned a ₹105 Cr investment to double cheese manufacturing capacity from 60 MT\u002Fday to 120 MT\u002Fday, to be completed by FY28.\n*   \u003Cb>New CFO Appointed:\u003C\u002Fb> Mr. Rakesh Kothari has been elevated to the position of Chief Financial Officer (CFO), effective August 7, 2026.\n*   \u003Cb>Segment Performance:\u003C\u002Fb> The \"New Age Business\" (Pride of Cows, Avvatar) was a standout, growing 59% YoY. In contrast, \"Flagship Categories\" saw a 2% volume decline.\n*   \u003Cb>Margin Pressure:\u003C\u002Fb> Profitability was impacted by a 13% YoY increase in milk procurement prices and sustained inflation.",{"company_name":44,"filing_date":45,"filing_source":17,"headline":46,"id":47,"stock_code":48,"summary_text":49},"EIH Limited","2026-08-07T00:28:27.066000","Q1 FY27 Earnings Conference Call Scheduled","6a74d977443983a806c857f2","EIHOTEL","• The company will host an earnings conference call to discuss its financial results for the quarter ended June 30, 2026 (Q1 FY27).\n• \u003Cb>Date & Time:\u003C\u002Fb> August 12, 2026, at 11:00 AM.\n• \u003Cb>How to Join:\u003C\u002Fb> The call will be conducted virtually via Microsoft Teams. The meeting link is available in the official announcement.",{"company_name":51,"filing_date":52,"filing_source":17,"headline":53,"id":54,"stock_code":55,"summary_text":56},"Britannia Industries Limited","2026-08-07T00:18:27.175000","Britannia Appoints New Senior Management Personnel","6a74d71f6da41605fd85ed85","BRITANNIA","*   The company has appointed two new Senior Management Personnel, effective August 1, 2026.\n*   \u003Cb>Mr. Piyush Bhandari\u003C\u002Fb> has been appointed as Vice President - Commercial. He has been with Britannia since 2006.\n*   \u003Cb>Mr. Abhishek Gaurav\u003C\u002Fb> has been appointed as Vice President - Replenishment. He has been with Britannia since 2008.\n*   Both appointments are promotions of long-serving internal candidates who joined the company as Management Trainees.",{"company_name":58,"filing_date":59,"filing_source":17,"headline":60,"id":61,"stock_code":62,"summary_text":63},"ICICI Bank Limited","2026-08-07T00:08:27.140000","Announces Pricing of $300M Senior Notes","6a74d4c8179efb336c2282fe","ICICIBANK","• **Issue Size:** USD 300 million\n• **Security Type:** Senior Unsecured Fixed Rate Notes\n• **Coupon Rate:** 5.352% per annum\n• **Tenure:** 5 years, maturing on August 13, 2031\n• **Use of Proceeds:** General corporate purposes\n• **Listing:** To be listed on the India International Exchange IFSC and NSE IFSC",{"company_name":58,"filing_date":65,"filing_source":17,"headline":66,"id":67,"stock_code":62,"summary_text":68},"2026-08-07T00:03:27.047000","ICICI Bank Prices $300 Million Senior Note Issuance","6a74d39cceb4d5c317879943","*   Priced a **USD 300 million** offering of 5-year Senior Unsecured Fixed Rate Notes.\n*   The notes carry a fixed coupon of **5.352%** per annum, payable semi-annually.\n*   The notes will be issued through its IFSC Banking Unit and mature on August 13, 2031.\n*   Proceeds are intended for general corporate purposes.",false,100,27,2609]